All In MedTech

FDA Clearance Tracker · P140031-S047

SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Nov 20, 2017 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Nov 20, 2017

Approved

Time to decision

151 days

Received Jun 22, 2017. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P140031-S047
Device name
SAPIEN 3 TRANSCATHETER HEART VALVE AND ACCESSORIES
Applicant location
Irvine, CA
Received
Jun 22, 2017
Decided
Nov 20, 2017
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Postapproval Study Protocol - OSB
Original approval
P140031

Device type

Device class
Class III

Every decision under product code NPT

FDA's approval statement

As written in FDA's record.

Approval of the protocol for the post-approval study (PAS) protocol.

Source documents

Other decisions for Edwards Lifesciences, LLC

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.